About CT632

CT632 is a public research library at ct632.com. The name identifies this reading room; it is not a peptide product, a marketed chemical code, or an acronym we invented for SEO.

Our tagline, Read the research. Track your protocol., separates roles: CT632 summarizes cited literature; PeptIQ.io is Kris Chase’s tracking and education app when you and your clinician already use it for logs and reminders.

Authorship

Articles are authored and edited by Kris Chase as CT632 editorial. Drafting uses AI tools to organize notes from linked primary sources (PubMed, DOI registries, ClinicalTrials.gov, and official regulator pages). Kris selects sources, writes the narrative, and approves publish. CT632 does not claim medical credentials, independent peer review, or review by physicians on staff.

Relationship to PeptIQ LLC

CT632 is an editorial property of PeptIQ LLC, which also operates PeptIQ. PeptIQ sells app subscriptions and education tools; CT632 does not sell peptides or list vendors. Editorial cross-links to PeptIQ use verified public URLs only.

What we publish

• Research summaries with primary citations
• Study literacy checklists and FAQs with visible HTML answers
• Original schematic figures with source notes (not clinical outcome charts)

We do not publish dose calculators, sourcing guides, or treatment recommendations on CT632.

Corrections

Email hello@peptiq.io with subject CT632 correction, the page URL, and the primary source link. See contact for other inboxes.

Privacy

Read the privacy page for how this static site handles hosting logs and email.

Medical disclaimer

Content is educational. It is not medical advice, diagnosis, or treatment. Verify regulatory status with official sources and licensed clinicians.